Werner Lilienblum

2.2k citations
31 papers · 1.6k indexed · h-index 18

Werner Lilienblum

31 papers receiving 1.6k citations

Peers

Werner Lilienblum
Comparison fields: 5 of 129
  • Pharmacology 556
  • Chemical Health and Safety 21
  • Health, Toxicology and Mutagenesis 389
  • Cancer Research 255
  • Biochemistry 96
Replace Gregory L. Kedderis with:
Gregory L. Kedderis United States
Wolfram Parzefall Austria
Eivor Elovaara Finland
Tim J.B. Gray United Kingdom
Douglas E. Rickert United States
Charlotte Witmer United States
James K. Selkirk United States
Matthew Bryant United States
John Whysner United States
Charlene A. McQueen United States
Werner Lilienblum relative to Gregory L. Kedderis United States Gregory L. Kedderis's profile →
Citations per field
00.5×1.5×2.3×
Gregory L. Kedderis · 1×
Citations per year

Countries citing papers authored by Werner Lilienblum

Since Specialization
Citations

This map shows the geographic impact of Werner Lilienblum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Lilienblum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Lilienblum more than expected).

Fields of papers citing papers by Werner Lilienblum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Lilienblum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Lilienblum. The network helps show where Werner Lilienblum may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Werner Lilienblum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Werner Lilienblum Line = papers co-authored together Werner Lilienblum links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20153
2 201492
3 201413
4 2011273
5 2008208
6 200666
7 198715
8 19875
9 198762
10 19869
11 19866
12 198612
13 198513
14 198537
15 198422
16 19848
17 198233
18 198016
19 197925
20 197719

About Werner Lilienblum

Werner Lilienblum is a scholar working on Pharmacology, Cancer Research and Biochemistry, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Carcinogens and Genotoxicity Assessment (9 papers), Drug Transport and Resistance Mechanisms (6 papers), Alcohol Consumption and Health Effects (6 papers), Effects and risks of endocrine disrupting chemicals (5 papers), Inflammatory mediators and NSAID effects (5 papers), Analytical Chemistry and Chromatography (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Pharmacology (556 citations), Chemical Health and Safety (21 citations) and Health, Toxicology and Mutagenesis (389 citations). Werner Lilienblum has collaborated with scholars based in Germany and India. Frequent co-authors include Karl Walter Bock, H. Pfeil, Heidi Foth, Jan G. Hengstler, Klaus‐Michael Wollin, P.-J. Kramer, Hermann Schweinfurth, Thomas Gebel, Autar K. Walli and Regine Kahl.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026